tiprankstipranks
Exelixis (EXEL)
NASDAQ:EXEL

Compare Exelixis (EXEL) vs. Competitors

3,148 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Compare
Top Analysts' Price Target
Smart Score
Follow
Exelixis
$44.27
$11.79B
15.12
28.47%
7 Buy
7 Hold
1 Sell
Moderate Buy
BioMarin Pharmaceutical
$54.53
$10.49B
32.67
-3.18%
13 Buy
3 Hold
0 Sell
Strong Buy
Halozyme
$67.82
$7.92B
25.45
17.54%
4 Buy
1 Hold
0 Sell
Strong Buy
Incyte
$96.07
$19.30B
14.98
74.13%
8 Buy
8 Hold
1 Sell
Moderate Buy
Ascendis Pharma
$239.28
$14.69B
-50.22
66.94%
13 Buy
0 Hold
0 Sell
Strong Buy
BridgeBio Pharma
$74.59
$14.46B
-20.69
130.86%
19 Buy
0 Hold
0 Sell
Strong Buy

Performance Comparison

Ticker
Company Name
Price
Change
% Change
EXEL
Exelixis
44.27
8.53
23.87%
BMRN
BioMarin Pharmaceutical
54.53
-5.14
-8.61%
HALO
Halozyme
67.82
6.43
10.47%
INCY
Incyte
96.07
36.85
62.23%
ASND
Ascendis Pharma
239.28
83.78
53.88%
BBIO
BridgeBio Pharma
74.59
39.74
114.03%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts